Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
04/02/2009 | CA2698673A1 Use of a peptide as a therapeutic agent |
04/02/2009 | CA2698672A1 Use of a peptide as a therapeutic agent |
04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
04/01/2009 | EP2042505A1 Polymorphic forms of a GABAa agonist |
04/01/2009 | EP2042499A1 Salt of morpholine compound |
04/01/2009 | EP2042498A1 Crystal of benzoxadiazole derivative |
04/01/2009 | EP2042495A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
04/01/2009 | EP2042190A1 Ameliorating agent for brain damage |
04/01/2009 | EP2042189A1 Use of proinsulin for the preparation of a neuroprotective pharmaceutical composition, therapeutic composition containing it and applications thereof |
04/01/2009 | EP2042181A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
04/01/2009 | EP2042174A1 Adhesive preparation |
04/01/2009 | EP2042173A2 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
04/01/2009 | EP2042172A1 Use of tocopherol derivatives as inhibitors of the notch signalling pathway |
04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
04/01/2009 | EP2041143A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them |
04/01/2009 | EP2041142A1 Spirocyclic azaindole derivatives |
04/01/2009 | EP2041138A2 Pyrrolotriazine kinase inhibitors |
04/01/2009 | EP2041136A2 Selective antagonists of a2a adenosine receptors |
04/01/2009 | EP2041134A1 Novel 1,4-diaza-bicycloý3.2.2¨nonyl pyrimidinyl derivatives and their medical use |
04/01/2009 | EP2041133A1 Derivatives of imidazo [1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
04/01/2009 | EP2041131A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
04/01/2009 | EP2041127A2 Indole compounds |
04/01/2009 | EP2041124A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
04/01/2009 | EP2041088A1 Glycine transporter-1 inhibitors |
04/01/2009 | EP2041086A1 Indole compounds |
04/01/2009 | EP2041085A1 Pyrrole derivatives and their methods of use |
04/01/2009 | EP2041084A1 Co-crystals of pyrrolidinones |
04/01/2009 | EP2041082A1 Pyrrolidine derivatives having activity at the glyt1 transporter |
04/01/2009 | EP2041079A1 Arylsulfonyl naphthalene derivatives and uses thereof |
04/01/2009 | EP2040755A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
04/01/2009 | EP2040739A2 Use of inducer of promyelocytic leukemia protein (pml) for treating polyglutamine expansion neurodegenerative diseases |
04/01/2009 | EP2040736A1 New formulation for increasing bioavailability of neurturin |
04/01/2009 | EP2040733A2 Method for elevating prolactin in mammals |
04/01/2009 | EP2040706A2 Modulators of muscarinic receptors |
04/01/2009 | EP2040705A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
04/01/2009 | EP2040703A2 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics |
04/01/2009 | EP2040700A1 N- (phenylmethyl) -2- (1h-pyraz0l-4-yl) acetamide derivatives as p2x7 antagonists for the treatment of pain, inflammation and neurodegeneration |
04/01/2009 | EP2040685A2 Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means |
04/01/2009 | EP1773770B1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
04/01/2009 | EP1664012B1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
04/01/2009 | EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
04/01/2009 | EP1473295B1 Fused bicyclic pyrimidine derivatives |
04/01/2009 | EP1458388B1 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
04/01/2009 | EP1456239B1 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |
04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
04/01/2009 | EP1137666B9 Glp-1 analogues |
04/01/2009 | EP1123087B1 Oral pulsed dose drug delivery system |
04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
04/01/2009 | CN101400703A Domain antibody construct |
04/01/2009 | CN101400677A Compounds |
04/01/2009 | CN101400672A Pyrazolylquinazolinones as potassium channel openers |
04/01/2009 | CN101400659A Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
04/01/2009 | CN101400657A Polycyclic cinnamide derivative |
04/01/2009 | CN101400407A Tropane prodrugs with central nervous system activity |
04/01/2009 | CN101400353A Use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
04/01/2009 | CN101400348A Tetrahydroisoquinoline derivatives to enhance memory function |
04/01/2009 | CN101400344A Composition for improving cellular membrane composition and function |
04/01/2009 | CN101400342A Controlled release formulation of divalproic acid and its derivatives |
04/01/2009 | CN101397573A Retroviral vector for expression of glial cell line-derived neurotrophic factor and use thereof |
04/01/2009 | CN101397336A Antigenic Neisserial peptides |
04/01/2009 | CN101397327A Method for preparing dihydro ginsenoside Rg2 and use thereof |
04/01/2009 | CN101397326A Ginsenoside Rb1 containing impurity ginsenoside Rg2 |
04/01/2009 | CN101397295A 2-dihydroindolemanone derivates as histone deacetylase inhibitor, preparation method and use thereof |
04/01/2009 | CN101397270A Polymorphic substance of donepezil salt, preparation and use thereof |
04/01/2009 | CN101396527A Traditional Chinese medicine formulation for treating migraine |
04/01/2009 | CN101396526A Traditional Chinese medicine composite preparation for treating migraine containing different medicine-releasing ways |
04/01/2009 | CN101396513A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396512A Traditional Chinese medicine formulation for treating insomnia |
04/01/2009 | CN101396505A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396504A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396503A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396502A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396501A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396500A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396494A Traditional Chinese medicine preparation for treating schizophrenia and preparation method and restorative medicine thereof |
04/01/2009 | CN101396490A Traditional Chinese medicine for treating headache of the blood vessel |
04/01/2009 | CN101396484A Composite valerian extract capable of tranquilizing and allaying excitement and production method thereof |
04/01/2009 | CN101396477A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396476A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396475A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396474A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396473A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396472A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396471A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396456A Traditional Chinese medicine for treating peripheral nerve lesion of diabetes |
04/01/2009 | CN101396433A Manufacture method of decoction capable of correcting facial paralysis for 2 hours |
04/01/2009 | CN101396419A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396418A Medicine composition for preventing the birth defect and improving the memory |
04/01/2009 | CN101396416A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396415A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396414A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396413A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396412A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396411A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396410A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
04/01/2009 | CN101396409A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |